Drug: Viokace (pancrelipase)

Manufacturer: Aptalis Pharma

Route of Administration: Oral

Site of Care: Outpatient

Approved Indication: in combination with a proton pump inhibitor, for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy in adults

Disease: exocrine pancreatic insufficiency

Therapeutic Area: Gastroenterology

Enrollment Form Link: N/A

Phone Number: N/A

Fax Number: N/A

Product Website: N/A